All right. Thank you.
Physicians will see gaps in access to medications. We're hearing this a lot. Can you speak to the challenge your members are hearing right now about what's happening in terms of whether we have a relative lack of pharmaceutical sovereignty and how clinicians are saying this is affecting their patients?
